Valbenazine for tardive dyskinesia: A systematic review of the efficacy and safety profile for this newly approved novel medication-What is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
about
Deutetrabenazine for tardive dyskinesia: A systematic review of the efficacy and safety profile for this newly approved novel medication-What is the number needed to treat, number needed to harm and likelihood to be helped or harmed?Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials.Management of common adverse effects of antipsychotic medications
P2860
Valbenazine for tardive dyskinesia: A systematic review of the efficacy and safety profile for this newly approved novel medication-What is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Valbenazine for tardive dyskin ...... lihood to be helped or harmed?
@en
type
label
Valbenazine for tardive dyskin ...... lihood to be helped or harmed?
@en
prefLabel
Valbenazine for tardive dyskin ...... lihood to be helped or harmed?
@en
P2860
P356
P1476
Valbenazine for tardive dyskin ...... lihood to be helped or harmed?
@en
P2860
P356
10.1111/IJCP.12964
P577
2017-05-12T00:00:00Z